Morgan Lewis has expanded its capabilities in the life sciences sector with the addition of Hiroshi Sheraton and Luciana Griebel as partners in the firm’s London office. The appointments were announced on Monday.
Hiroshi Sheraton’s practice specializes in contentious patent and trademark issues and life sciences matters. He has extensive experience coordinating pan-European and global intellectual property litigation. Sheraton also advises clients on international IP strategies for patent litigation and various forms of exclusivity, and represents life sciences clients in IP licensing, collaboration, and development matters. More details on Sheraton’s practice can be found here.
Luciana Griebel frequently advises on cross-border transactions and works with companies at all stages of development, as well as investors and management teams. Her role in the firm will further enhance Morgan Lewis’s offerings in the life sciences field, particularly in areas involving complex transactions and strategic advisory services.
This move underscores Morgan Lewis’s commitment to strengthening its presence in the highly competitive and evolving life sciences sector, particularly in the European market.